3-Aminopyrazin-2(1H)-one - CAS 43029-19-2
Catalog: |
BB025304 |
Product Name: |
3-Aminopyrazin-2(1H)-one |
CAS: |
43029-19-2 |
Synonyms: |
3-amino-1H-pyrazin-2-one; 3-amino-1H-pyrazin-2-one |
IUPAC Name: | 3-amino-1H-pyrazin-2-one |
Description: | 3-Aminopyrazin-2(1H)-one (CAS# 43029-19-2) is a compound used in the design and synthesis of various 2(1H)-pyrazinones as inhibitors of protein kinases. |
Molecular Weight: | 111.10 |
Molecular Formula: | C4H5N3O |
Canonical SMILES: | C1=CN=C(C(=O)N1)N |
InChI: | InChI=1S/C4H5N3O/c5-3-4(8)7-2-1-6-3/h1-2H,(H2,5,6)(H,7,8) |
InChI Key: | KQLHRXQKORXSTC-UHFFFAOYSA-N |
Boiling Point: | 538.9 °C at 760 mmHg |
Density: | 1.55 g/cm3 |
MDL: | MFCD01646052 |
LogP: | 0.34560 |
Publication Number | Title | Priority Date |
WO-2015166366-A1 | Heterocyclic compounds and their use as dopamine d1 ligands | 20140428 |
WO-2015166370-A1 | Heteroaromatic compounds and their use as dopamine d1 ligands | 20140428 |
US-2015307494-A1 | Heteroaromatic compounds and their use as dopamine d1 ligands | 20140425 |
US-2015307522-A1 | Heteroaromatic compounds and their use as dopamine d1 ligands | 20140425 |
WO-2015162515-A1 | Heteroaromatic compounds and their use as dopamine d1 ligands | 20140425 |
PMID | Publication Date | Title | Journal |
21295466 | 20110301 | P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position | Bioorganic & medicinal chemistry letters |
15911253 | 20050602 | P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold | Bioorganic & medicinal chemistry letters |
14604352 | 20031114 | Synthesis of 3-aminopyrazinone mediated by 2-pyridylthioimidate-ZnCl2 complexes. Development of an efficient route to a thrombin inhibitor | The Journal of organic chemistry |
14570777 | 20031101 | Bioactivation of the 3-amino-6-chloropyrazinone ring in a thrombin inhibitor leads to novel dihydro-imidazole and imidazolidine derivatives: structures and mechanism using 13C-labels, mass spectrometry, and NMR | Drug metabolism and disposition: the biological fate of chemicals |
12570369 | 20030213 | Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines | Journal of medicinal chemistry |
Complexity: | 170 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 111.043261792 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 111.043261792 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 67.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyrazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS